Effects of antenatal magnesium sulfate and corticosteroid therapy on sleep states of preterm infants

Research in Nursing and Health

Volumn 29, Issue 4, 2006, Pages 269-280

  Black, Beth ^a   Holditch Davis, Diane ^b   Schwartz, Todd ^c   Scher, Mark S ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY   (United States)

^c IL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroids; Magnesium sulfate; Preterm infants; Respiration; Sleep

Indexed keywords

CORTICOSTEROID; MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ANALYSIS OF VARIANCE; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PREGNANCY; PREMATURITY; SLEEP;

ADRENAL CORTEX HORMONES; ANALYSIS OF VARIANCE; BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LONGITUDINAL STUDIES; MAGNESIUM SULFATE; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; SLEEP; TOCOLYTIC AGENTS;

EID: 33748105119     PISSN: 01606891     EISSN: 1098240X     Source Type: Journal    
DOI: 10.1002/nur.20141     Document Type: Article

References (48)

1. Abbasi, S., Hirsch, D., Davis, J., Tolosa, J., Stouffer, N., Debbs, R., et al. (2000). Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. American Journal of Obstetrics and Gynecology, 182, 1243-1249.
2. Blumberg, M.S., & Lucas, D.E. (1996). A developmental and component analysis of active sleep. Developmental Psychobiology, 29, 1-22.
3. Borghese, I.F., Minard, K.L., & Thoman, E.B. (1995). Sleep rhythmicity in premature infants: Implications for development status. Sleep, 18, 523-530.
4. Brazy, J.E., Eckerman, C.O., Oehler, J.M., Goldstein, R.F., & O'Rand, A.M. (1991). Nursery neurobiologic risk score: Important factor in predicting outcome in very low birth weight infants. Journal of Pediatrics, 118, 783-792.
5. Brazy, J.E., Goldstein, R.F., Oehler, J.M., Gustafson, K.E., & Thompson, R.J., Jr. (1993). Nursery neurobiological risk score: Levels of risk and relationships with nonmedical factors. Journal of Developmental and Behavioral Pediatrics, 14, 375-380.
6. Canterino, J.C., Verma, U., Visintainer, P., Figueroa, R., Klein, S., & Tejani, N. (1999). Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstetrics and Gynecology, 93, 396-402.
7. Crowther, C.A., Hiller, J.E., Doyle,. L.W., & Haslam, R.R. (2003). Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA, 290, 2669-2676.
8. Curzi-Dascalova, L., Figueroa, J., Eiselt, M., Christova, E., Virassamy, A., d'Allest, A. M., et al. (1993). Sleep state organization in premature infants of less than 35 weeks' gestational age. Pediatric Research, 34, 624-628.
9. DiPietro, J.A., & Porges, S.W. (1991). Relations between neonatal states and 8-month developmental outcome in preterm infants. Infant Behavior and Development, 14, 441-450.
10. Doussard-Roosevelt, J., Porges, S.W., & McClenny, B.D. (1996). Behavioral sleep states in very low birth weight preterm neonates: Relation to neonatal health and vagal maturation. Journal of Pediatric Psychology, 21, 785-802.
11. Edwards, L.J., (2000). Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatric Pulmonology, 30, 330-344.
12. Edwards, L.J., Stewart, P.W., Muller, K.E., & Helms, R.W. (2001). Linear equality constraints in the general linear mixed model. Biometrics, 57, 1185-1190.
13. Elimian, A., Verma, R., Ogburn, P., Wiencek, V., Spitzer, A., & Quirk, J.G. (2002). Magnesium sulfate and neonatal outcomes of preterm neonates. Journal of Maternal-Fetal and Neonatal Medicine, 12, 118-122.
14. Fairclough, D.L., & Helms, R.W. (1986). A mixed linear model with linear covariance structure: A sensitivity analysis of the maximum likelihood estimators. Journal of Statistical Computation and Simulation, 25, 205-206.
15. Fajardo, B., Browning, M., Fisher, D., & Paton, J. (1992). Early state organization and follow-up over one year. Journal of Developmental and Behavioral Pediatrics, 13, 83-88.
16. Farkouh, L.J., Thorp, J.A., Jones, P.G., Clark, R.H., & Knox, G.E. (2001). Antenatal magnesium exposure and neonatal demise. American Journal of Obstetrics and Gynecology, 185, 869-872.
17. French, N.P., Hagan, R., Evans, S.F., Godfrey, R., & Newnham, J.P. (1999). Repeated antenatal corticosteroids: Size at birth and subsequent development. American Journal of Obstetrics and Gynecology, 180, 114-121.
18. Gertner, S., Greenbaum, C.W., Sadeh, A., Dolfin, Z., Sirota, L., & Ben-Nun, Y. (2002). Sleep-wake patterns in preterm infants and 6 month's home environment: Implications for early cognitive development. Early Human Development, 68, 93-102.
19. Gray, P.H., Jones, P., & O'Callaghan, M.J. (2001). Maternal antecedents for cerebral palsy in extremely preterm babies: A case-control study. Developmental Medicine and Child Neurology, 43, 580-585.
20. Grether, J.K., & Nelson, K.B. (1997). Maternal infection and cerebral palsy in infants of normal birth weight. JAMA, 278, 207-211.
21. Guinn, D., Atkinson, M., Sullivan, L., Lee, M., MacGregor, S., & Parilla, B., et al. (2001). Single vs. weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA, 286, 1581-1587.
22. Halpern, L.F., MacLean, W.E., Jr. & Baumeister, A.A. (1995). Infant sleep-wake characteristics: Relation to neurological status and the prediction of developmental outcome. Developmental Review, 15, 255-291.
23. Holditch-Davis, D. (1990). The development of sleeping and waking states in high-risk preterm infants. Infant Behavior and Development, 15, 513-531.
24. Holditch-Davis, D. (2003). Final report: Assessment of biological and social risk in preterm infants, R01 NR01894. National Institute for Nursing Research, NIH. 6/1/98-2/28/03.
25. Holditch-Davis, D., Belyea, M., & Edwards, L. (2005). Prediction of 3-year developmental outcomes from sleep development over the preterm period. Infant Behavior and Development, 28, 118-131.
26. Holditch-Davis, D., & Edwards, L. (1998a). Modeling development of sleep-wake behaviors. II. Results of two cohorts of preterms. Physiology and Behavior, 63, 319-328.
27. Holditch-Davis, D., & Edwards, L. (1998b). Temporal organization of sleep-wake states in preterm infants. Developmental Psychobiology. 33, 257-269.
28. Holditch-Davis, D., Edwards, L., & Helms, R. (1998). Modeling development of sleep-wake behaviors: I. Using the mixed general linear model. Physiology and Behavior, 63, 311-318.
29. Holditch-Davis, D., Edwards, L.J., & Wigger, M.C. (1994). Pathologic apnea and brief respiratory pauses in preterm infants: Relation to sleep state. Nursing Research, 43, 293-300.
30. Holditch-Davis, D., Scher, M. & Schwartz, T. (2004). Respiratory development in preterm infants. Journal of Perinatology, 24, 631-639.
31. Holditch-Davis, D., Scher, M., Schwartz, T., & Hudson-Barr, D. (2004). Sleeping and waking state development in preterm infants. Early Human Development, 80(1), 43-64.
32. Holditch Davis, D., & Thoman, E.B. (1987). Behavioral states of premature infants: Implications for neural and behavioral development. Developmental Psychobiology, 20, 25-38.
33. Ingersoll, E.W., & Thoman, E.B. (1999). Sleep/wake states of preterm infants: Stability, developmental change, diurnal variation, and relation with care giving activity. Child Development, 70, 1-10.
34. Laird, N.M., & Ware, J.H. (1982). Random-effects models for longitudinal data. Biometrics, 38, 968-974.
35. Mittendorf, R., Covert, R., Boman, J., Khoshnood, B., Lee, K.S., & Siegler, M. (1997). Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet, 350, 1517-1518.
36. Mittendorf, R., Dambrosia, J., Pryde, P.G., Lee, K.S., Gianopoulos, J.G., Besinger, R.E., et al. (2002). Association between the use of antenatal magnesium sulfatein preterm labor and adverse health outcomes in infants. Journal of Obstetrics and Gynecology, 186, 1111-1118.
37. Moore, M.L. (2003). Preterm labor and birth: What have we learned in the past two decades? Journal of Obstetric, Gynecologic and Neonatal Nursing, 32, 638-649.
38. Muller, K.E., & Fetterman, B.A. (2002). Regression and ANOVA: An integrated approach using SAS software. Cary, NC: SAS Institute, Inc.
39. Scher, M.S., Jones, B.V., Steppe, D.A., Cork, D.L., Seltman, H.J., & Banks, D.L. (2003). Functional brain maturation in neonates as measured by EEG-sleep analyses. Clinical Neurophysiology, 114, 875-882.
40. Scher, M.S., Waisanen, H., Loparo, K., & Johnson, M.W. (2005). Prediction of neonatal state and maturational change using dimensional analysis. Journal of Clinical Neurophysiology, 22, 159-165.
41. Scudiero, R., Khoshnood, B., Pryde, P.G., Lee, K.S., Wall, S., & Mittendorf, R. (2000). Perinatal death and tocolytic magnesium sulfate. Obstetrics and Gynecology, 96, 178-182.
42. Sibai, B.M. (2002). Hypertension in pregnancy. In S.G. Gabbe, J.R. Niebyl, & J.L. Simpson (Eds.), Obstetrics: Normal and problem pregnancies, (pp. 323-354). Philadelphia: Elsevier Science.
43. Thoman, E.B. (1982). A biological perspective and a behavioral model for assessment of premature infants. In L. A. Bond & J. M. Joffee (Eds.), Primary prevention of psychopathology: Facilitating infant and early childhood development (Vol. 6, pp. 159-179). Hanover, NH: University Press of New England.
44. Thorp, J.A., Jones, A.M., Hunt, C., & Clark, R. (2001). The effect of multidose antenatal betamethasone on maternal and infant outcomes. American Journal of Obstetrics and Gynecology, 184, 192-202.
45. Vermillion, S.T., Soper. D.E., & Chasedunn-Roark, J. (1999). Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology, 181, 320-327.
46. Vohr, B.R., Karp, D., O'Dea, C., Darrow, D., Coll, C.G., Lester, B.M., et al. (1990). Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. The Journal of Pediatrics, 117, 288-291.
47. Witcher, R. (2002). Treatment of preterm labor. Journal of Perinatal and Neonatal Nursing, 16, 25-46.
48. Witlin, A., & Sibai, B. (1998). Magnesium sulfate therapy in preeclampsia and eclampsia. Obstetrics and Gynecology, 92, 883-889.